Replies to post #25630 on PharmaCyte Biotech Inc (PMCB)

[$Pistol Pete$]

Thanks Bull. This is great news for long term investors. It is going to attract new investors who believe in CiaB Technology.
$NVLX

Pistol Pete!

[Peacefulwendy]

This is actually good news and shows that Nuvilex has met important requirements significant to shareholders that would allow them to continue to be traded on the OTCQB. The standards have risen as a result of CEO and CFO requests. The fact that we met those standards is good for us and good for the OTCQB market in general.

Thanks for the DD, bull... BTW, this was effective May 1, 2014.

Beginning this year, OTC Markets Group will roll out new eligibility standards for the OTCQB® Venture Stage Marketplace. To be eligible to trade on OTCQB, companies will be required to meet a new bid price test, provide additional information, and submit an annual OTCQB Certification signed by the company CEO or CFO.

Companies will also be required to submit an initial application and pay an annual fee for OTCQB, which will now include Level 2 Quotes and the OTC Disclosure & News Service. We expect that companies that do not either meet the new OTCQB standards or qualify for OTCQX® will continue to be traded by broker-dealers on the OTC Pink® marketplace. This letter is to inform you of these changes and explain why we are creating new requirements on OTCQB. Please take a moment to read this important update.